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MaOBJECTIVES The aim of this study was to investigate early markers of arrhythmic events (AEs) and improve risk
stratiﬁcation in early arrhythmogenic right ventricular cardiomyopathy (ARVC).
BACKGROUND AEs are frequent in patients with ARVC, but risk stratiﬁcation in subjects with early ARVC is challenging.
METHODS Early ARVC disease was deﬁned as possible or borderline ARVC diagnosis according to the ARVC Task Force
Criteria 2010. We performed resting and signal averaged electrocardiogram (ECG). Using echocardiography, we assessed
right ventricular (RV) outﬂow tract diameter and right ventricular basal diameter (RV diameter). Global longitudinal
strain and mechanical dispersion (MD) from strain echocardiography were assessed in both the right and left ventricle.
AEs were deﬁned as documented ventricular tachycardia, cardiac syncope, or aborted cardiac arrest.
RESULTS Of 162 included subjects with ARVC (41  16 years of age, 47% female), 73 had early ARVC, including
mutation positive family members not fulﬁlling deﬁnite ARVC diagnosis. AEs occurred in 15 (21%) subjects with early
ARVC. Those with AEs in early disease had larger RV diameter (40  4 mm vs. 37  5 mm), more pronounced RVMD (39 
15 ms vs. 26  11 ms), and more pathological signal averaged ECGs compared with those without AEs (all p # 0.05).
Adding measurements of RV diameter and RVMD to electrical parameters improved identiﬁcation of subjects with AEs
compared with electrical parameters alone (p ¼ 0.05).
CONCLUSIONS ECG parameters, RV diameter, and RVMD were markers of previous arrhythmic events in patients
with early ARVC. A combination of electrical and echocardiographic parameters improved identiﬁcation of subjects
with AEs in early ARVC disease. (J Am Coll Cardiol Img 2016;-:-–-) © 2016 by the American College of
Cardiology Foundation. Published by Elsevier. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).A rrhythmogenic right ventricular cardiomyop-athy (ARVC) is an inheritable cardiomyopa-thy that predisposes to life-threatening
arrhythmias and heart failure, and is one of the lead-
ing causes of sudden cardiac death (SCD) in young in-
dividuals (1). Ventricular arrhythmias are frequent in
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ABBR EV I A T I ON S
AND ACRONYMS
AIC = Akaike information
criterion
ARVC = arrhythmogenic right
ventricular cardiomyopathy
CI = conﬁdence interval
ECG = electrocardiogram
ICD = implantable cardioverter
deﬁbrillator
LV = left ventricular
LVEF = left ventricular ejection
fraction
ROC = receiver operating
characteristic
RV = right ventricular
RV FAC = RV fractional area
change
RVOT = right ventricular
outﬂow tract
SCD = sudden cardiac death
TFC 2010 = ARVC Task Force
Criteria, revised in 2010
VT = ventricular tachycardia
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2stratiﬁcation has moved from assessing
obvious myocardial pathology to predicting
the transition from asymptomatic, mutation
positive ARVC to electrical disease with
potential life-threatening ventricular arrhy-
thmias (3). Of importance, outcome is favor-
able in patients detected early and treated
according to guidelines (4). Tools are needed
to detect early disease and to optimize medi-
cation and timing of implantation of a cardi-
overter deﬁbrillator (ICD) to prevent SCD
becoming the ﬁrst symptom of ARVC.
The Task Force Criteria revised in 2010
(TFC 2010) improved sensitivity and speci-
ﬁcity of ARVC diagnosis (5). Newer echo-
cardiographic techniques, such as strain
echocardiography, have shown promising
results in ARVC risk stratiﬁcation in previous
studies (6,7). We aimed to explore early
markers of ARVC disease and their associa-
tion with previous ventricular arrhythmias.
We hypothesized that a combination of
electrocardiographic parameters and imaging
parameters, including strain echocardiogra-phy, may improve risk stratiﬁcation of arrhythmic
events in subjects with ARVC.
METHODS
STUDY POPULATION. In this cross-sectional study,
consecutive patients referred to the Department of
Cardiology, Oslo University Hospital, Rikshospitalet,
between 2008 and 2014 with suspected ARVC were
evaluated for inclusion. Probands were genetically
screened and family members of probands with
disease-causing mutations were tested and included
if mutation-positive. All patients fulﬁlling borderline,
possible, or deﬁnite ARVC diagnosis by the TFC 2010
(5) at their visit were invited to participate. No patient
refused consent to participate. Exclusion criteria
were signiﬁcant ischemic heart disease or coexisting
heart disease of other origin. All participants under-
went clinical examination. Arrhythmic events were
reviewed retrospectively at inclusion and deﬁned as
documented nonsustained or sustained ventricular
tachycardia (VT) by Holter monitoring, exercise test
or ICD recordings, syncope of suspected cardiac
origin, or aborted cardiac arrest. Medication use, ICD
presence, and eventual prior ICD therapies at the time
of the echocardiographic examination were recorded.
ELECTROCARDIOGRAPHY. Twelve-lead electrocar-
diogram (ECG) was obtained at the time of the echo-
cardiographic examination. Signal-averaged ECGs
were performed (8) and patients with complete bundlebranch block were excluded from signal-averaged
ECGs analyses (5). S-wave upstroke was measured as
the time from the nadir of the S-wave to the isoelectric
line (9).
ECHOCARDIOGRAPHIC STUDIES. Two-dimensional
echocardiographic studies were performed on a Vivid
7 or 9 (GE Healthcare, Horten, Norway) and data were
analyzed with EchoPAC version 112 (GE Healthcare).
Data analyses were performed blinded to patient
clinical data.
From2-dimensional echocardiography,we assessed
proximal right ventricular outﬂow tract (RVOT) diam-
eter in the parasternal short-axis view. We assessed
right ventricular basal diameter (RV diameter) and
right ventricular fractional area change (RV FAC) from
the 4-chamber view (10). Left ventricular (LV) end-
diastolic volume, LV end-systolic volume, and left
ventricular ejection fraction (LVEF) were calculated by
the modiﬁed Simpson biplane method.
We assessed longitudinal strains by speckle
tracking technique from the 3 apical views for LV
global longitudinal strain (11) and from the 4-chamber
view for right ventricular (RV) global longitudinal
strain, all at frame rates >50/s. The endocardial
border was traced in each view. The operator manu-
ally adjusted segments that failed to track; segments
that subsequently failed to track were excluded. LV
global longitudinal strain was deﬁned as the average
of peak negative longitudinal strain from a 16-
segment LV model (11). LV mechanical dispersion
was deﬁned as the standard deviation of time from
Q/R on the ECG to peak negative longitudinal strain in
the same 16 segments. Peak negative longitudinal
strain from 6 RV segments was averaged as a measure
of RV function (RV global longitudinal strain) (6). RV
mechanical dispersion was calculated as the SD of
time from Q/R on ECG to peak negative longitudinal
strain from 6 RV segments (Figure 1).
CARDIAC MAGNETIC RESONANCE. Cardiac magnetic
resonance was performed as previously described (12)
and parameters for TFC 2010 were analyzed (5).
STAGING OF ARVC DISEASE. To assess the stage of
ARVC disease (overt or early), we used the TFC 2010
criteria (5). Patients who fulﬁlled deﬁnite ARVC
diagnosis ($2 major or 4 minor criteria, or 1 major and
2 minor criteria) were deﬁned as overt ARVC. Subjects
fulﬁlling borderline ARVC (1 major þ 1 minor or 3
minor criteria) and possible ARVC (1 major or 2 minor
criteria) were deﬁned as early ARVC.
GENETIC ANALYSES. Genetic testing was performed
as previously described (12) as part of the diagnostic
workup in subjects with suspected ARVC. Cascade
genetic screening was performed in family members
FIGURE 1 Measurement of RV Mechanical Dispersion
Red horizontal arrows indicate time to peak strain, deﬁned as time from onset of Q/R on ECG to peak negative strain. Blue vertical line indicates onset of Q/R on ECG. RV
mechanical dispersion was deﬁned as the standard deviation of contraction duration from 6 RV segments. ECG ¼ electrocardiogram; RV ¼ right ventricular.
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3of mutation-positive index patients. Only family
members of ARVC patients with conﬁrmed patho-
genic mutations were included.
STATISTICAL ANALYSES. Comparisons of pro-
portions were performed by the chi-square test or
Fisher exact test when appropriate. Continuous data
were presented as mean  SD and compared by un-
paired Student t test (SPSS version 21.0, SPSS Inc.,
Chicago, Illinois). Multivariable logistic regression
analyses were used to adjust for beta-blocker use,
age, sex, and mutation status in the total ARVC pop-
ulation. Overﬁtting was tested with Akaike informa-
tion criterion (AIC).
Correlations between continuous parameters were
assessed by linear regression. The C-statistic was
calculated by receiver operating characteristic (ROC)
curves. The value closest to the upper left corner of
the ROC curve was deﬁned as giving optimal sensi-
tivity and speciﬁcity. Comparisons of C-statistics
were performed with the software Analyze-it
(Analyse-it Software, Ltd., Leeds, United Kingdom).
We used likelihood ratios test to evaluate if echocar-
diographic parameters could improve the model for
identifying subjects with arrhythmic events
compared with electrical parameters only. Two sided
p values #0.05 were considered statistically signiﬁ-
cant. Intraobserver and interobserver variability an-
alyses were performed in 10 random study patients
and expressed by intraclass correlation values.All participants gave written informed consent.
The study complied with the Declaration of Helsinki
and was approved by the Regional Committees for
Medical Research Ethics.
RESULTS
We included 162 subjects with ARVC, including 86
(53%) index patients and 76 (47%) mutation-positive
family members (41  16 years of age, 45% female)
(Table 1). A deﬁnite diagnosis of ARVC was present
in 89 (55%) subjects, deﬁned as overt ARVC, while
31 (19%) had borderline and 42 (26%) had possible
ARVC diagnosis (5), deﬁned as early ARVC disease
(n ¼ 73, 45%). Of subjects with early ARVC, 58 (79%)
were mutation-positive family members and 15 (21%)
had clinically suspected ARVC in addition to ful-
ﬁlling possible or borderline ARVC diagnostic
criteria.
Arrhythmic events occurred in 84 (52%) subjects in
total; 69 (78%) with overt and 15 (21%) with early
ARVC. Median time from ﬁrst arrhythmic event to
echocardiography was 3.2 months (interquartile
range: 0.1 months, 5.9 years). At time of echocardi-
ography, 57 (35%) patients were treated with beta
blockers, 10 (6%) with amiodarone, and 1 (1%) with
ﬂecainide. Also, 50 (31%) patients had or were
implanted with an ICD at the time of study inclusion,
including 4 subjects with early ARVC. Appropriate
TABLE 1 Clinical Characteristics in 162 Subjects With ARVC
Subjects With ARVC (n ¼ 162)
Age, yrs 41  16
BMI, kg/m2 25.5  4.5
Cardiac arrest 17 (10)
Deﬁnite/borderline/possible 89/31/42
Female 76 (47)
Resting heart rate, beats/min 63  13
Index patients 86 (53)
Syncope 47 (29)
Ventricular arrhythmias 84 (52)
Values are mean  SD, n (%), or n.
AVRC ¼ arrhythmogenic right ventricular cardiomyopathy; BMI ¼ body mass
index.
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4ICD therapies had been given in 15 patients, none of
whom had early disease.
Overt ARVC subjects had changes in all TFC 2010
(5) diagnostic categories, with the exception of tissuetion of Parameters for ARVC Diagnosis From the Task Force Criteria in 89
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t ARVC, diagnosis was based on ﬁndings from all categories from the Task F
sing data). Diagnosis in patients with early ARVC was mainly based on genetic
on waves (major) or abnormal signal-averaged ECG (minor). Repolarization:
enic right ventricular cardiomyopathy; other abbreviations as in Figure 1.characterization by endomyocardial biopsy, which
was missing in the majority of subjects (Figure 2). The
diagnosis of early ARVC was mainly based on family
mutations (n ¼ 58), minor depolarization abnormal-
ities (n ¼ 22), and minor criteria for ventricular
arrhythmias (n ¼ 15) (Figure 2). Cardiac magnetic
resonance was performed in 121 (75%) subjects with
ARVC, including 50 (68%) with early ARVC.
TOTAL ARVC POPULATION. In the total ARVC pop-
ulation, RV and RVOT diameters were markers of
arrhythmic events (both p < 0.001) (Table 2). RV
function by RV FAC and RV global longitudinal strain
were decreased in subjects with arrhythmic events
(both p < 0.01) (Table 2) and RV mechanical disper-
sion was more pronounced (p ¼ 0.001). By ROC ana-
lyses, RV diameter had a marginally higher C-statistic
to detect subjects with arrhythmic events compared
with RVOT diameter (0.78 [95% conﬁdence interval
(CI): 0.71 to 0.85] vs. 0.70 [95% CI: 0.62 to 0.78];Overt and 73 Subjects With Early ARVC
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orce Criteria revised in 2010, with the exception of tissue
mutations, minor depolarization abnormalities, and minor arrhythmias.
ECG T-wave inversions (V1-V2 [minor], V1-V3 or beyond [major]).
TABLE 2 Comparison of Subjects With ARVC Without and With Arrhythmic Events in the
Total ARVC Population
No Arrhythmic
Events
(n ¼ 78)
Arrhythmic
Events
(n ¼ 84) p Value
Deﬁnite/borderline/possible 20/21/37 69/10/5
Female 45 (58) 31 (37) 0.008
Echocardiography
RV diameter, mm 38  6 46  9 <0.001
RV FAC, % 44  9 35  10 <0.001
RV GLS, % (6 segments) -24.1  3.4 -21.1  5.7 0.001
RV mechanical dispersion, ms (6 segments) 30  16 45  27 0.001
RVOT sax, mm 32  5 38  9 <0.001
LVEDV, ml 110  26 121  45 0.07
LVESV, ml 47  13 58  36 0.02
LVEF, % 58  4 54  9 0.001
LV GLS, % (16 segments) -20.4  2.4 -19.2  4.1 0.03
LV mechanical dispersion, ms (16 segments) 34  13 48  34 0.002
Electrical parameters
Filtered QRS, ms 111  9 125  24 <0.001
HFLA, ms 34  9 46  25 <0.001
RMS, mV 36  16 24  18 <0.001
Epsilon waves 4 (5) 19 (23) 0.001
T-wave inversions 15 (19) 55 (65) <0.001
QRS, ms 93  14 97  18 0.13
Values are n, n (%), or mean  SD. p by independent Student t test or chi-square test.
GLS ¼ global longitudinal strain; HFLA ¼ high-frequency low-amplitude signals; LV ¼ left ventricular;
LVEDV ¼ left ventricular end-diastolic volume; LVEF ¼ left ventricular ejection fraction; LVESV ¼ left ventricular
end-systolic volume; RMS ¼ root-mean-square voltage of terminal 40 ms; RV diameter ¼ right ventricular basal
diameter; RV FAC ¼ right ventricular fractional area change; RV GLS ¼ right ventricular global longitudinal strain;
RVOT sax ¼ right ventricular outﬂow tract diameter from parasternal short-axis view.
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5p ¼ 0.06). An RV diameter of 41 mm and an RVOT
diameter of 34 mm optimally detected subjects with
arrhythmic events. RV and LV dimensions were larger
and RV function and LVEF were lower in those with
arrhythmic events (all p # 0.05) (Table 2), also when
adjusted for beta-blocker use, age, sex, and mutation
status in multivariable analyses (all p # 0.05).
QRS duration did not differ between ARVC with
and without arrhythmic events, whereas T-wave in-
versions were more prevalent in subjects with
arrhythmic events (p < 0.001) (Table 2). All 3 param-
eters from signal-averaged ECGs were markers of
arrhythmic events (all p < 0.001) (Table 2).
PATIENTS WITH OVERT ARVC. In patients with overt
ARVC, 69 (78%) had experienced arrhythmic events
(17 aborted cardiac arrests, 40 sustained VTs, 11
nonsustained VTs, and 1 cardiac syncope without
documented ventricular arrhythmia). Of the remain-
ing 20 (22%) with overt ARVC and no arrhythmic
events, 18 (90%) were ARVC-mutation positive. As
expected, increased RVOT diameter and decreased
RV FAC were markers of arrhythmic events. Inter-
estingly, also the new parameters RV diameter and
RV global longitudinal strain were arrhythmic
markers, with a similar ability to identify patients
with arrhythmic events (C-statistic, 0.75 [95% CI: 0.61
to 0.88] and 0.68 [95% CI: 0.54 to 0.82], respectively;
p ¼ 0.36). Parameters from signal-averaged ECGs
were abnormal in overt patients with ARVC, but were
not markers of arrhythmias (Online Table 1).
SUBJECTS WITH EARLY ARVC. In subjects with early
ARVC, 15 (21%) had experienced arrhythmic events
(5 sustained VT, 9 nonsustained VT, and 1 cardiac
syncope without documented VT). RV diameter was
larger in subjects with arrhythmic events (p ¼ 0.05,
Table 3) and RV mechanical dispersion was more pro-
nounced (p ¼ 0.003). By ROC analyses, RV mechanical
dispersion and RV diameter had similar ability to
detect arrhythmic events (C-statistic, 0.74 [95% CI:
0.59 to 0.90] and 0.62 [95% CI: 0.47 to 0.78, respec-
tively; p ¼ 0.20; optimal cutoffs were $37 ms and $40
mm, respectively). Neither standard parameters of RV
function (RV FAC, RV global longitudinal strain) nor
parameters of LV function were markers of arrhythmic
events in early ARVC (Table 3), whereas all parameters
from signal-averaged ECG were arrhythmic markers
(all p < 0.05) (Table 3) with comparable discriminative
ability (p > 0.59 for all comparisons). Optimal cutoff
values were $115 ms for ﬁltered QRS, $33 ms for high-
frequency low-amplitude signal and #32 mV for RMS
(sensitivity, speciﬁcity, and C-statistics, Online Ta-
ble 2). Interestingly, mechanical dispersion correlated
with the electrical parameter ﬁltered QRS durationfrom signal averaged ECG (R ¼ 0.38, p ¼ 0.009)
(Figure 3). There were no signiﬁcant differences in QRS
duration or presence of T-wave inversions (p ¼ 0.27)
between subjects with and without arrhythmic events
(Table 3). Only 1 subject had S-wave upstroke >55 ms
(Table 3).
EARLY ARVC ARRHYTHMIC RISK ASSESSMENT. To
assess arrhythmic risk in subjects with early ARVC,
we evaluated the presence of major and minor elec-
trical abnormalities as given by the TFC 2010 (5)
(depolarization: epsilon waves in V1 to V3, patholog-
ical signal-averaged ECG; repolarization: T-wave in-
versions). In patients with early ARVC and arrhythmic
events, 67% had abnormal electrical parameters
(8 [54%] depolarization and 2 [13%] repolarization
abnormalities by TFC 2010 [5]) and 67% had abnormal
echocardiographic ﬁndings by the early parameters
(RV diameter $40 mm and/or RV mechanical
dispersion $37 ms). Interestingly, 87% of those with
arrhythmias had at least 1 of the electrical or echo-
cardiographic abnormalities. We tested the ability of
major and minor electrical abnormalities to detect
subjects with arrhythmic events in a logistic regres-
sion model (Figure 4). The model’s ability to detect
TABLE 3 Comparison of 73 Subjects With Early ARVC Without and With
Arrhythmic Events
No Arrhythmic
Events
(n ¼ 58)
Arrhythmic
Events
(n ¼ 15) p Value
Female 32 (55) 6 (40) 0.29
Echocardiography
RV diameter, mm 37  5 40  4 0.05
RV FAC, % 45  8 43  6 0.45
RV GLS, % (6 segments) -24.2  3.3 -23.8  2.9 0.69
RV mechanical dispersion, ms (6 segments) 26  11 39  15 0.003
RVOT sax, mm 32  5 35  5 0.09
LVEDV, ml 112  28 115  31 0.75
LVESV, ml 48  14 50  15 0.69
LVEF, % 58  4 57  4 0.43
LV GLS, % (16 segments) -20.5  2.4 -20.1  1.7 0.57
LV mechanical dispersion, ms (16 segments) 33  14 39  31 0.28
Electrical parameters
Filtered QRS, ms 109  7 115  8 0.005
HFLA, ms 32  7 37  5 0.02
RMS, mV 38  14 27  13 0.02
Epsilon waves 0 (0) 2 (13) 0.04
Incomplete RBBB 2 (3) 1 (7) 0.59
QRS, ms 92  13 94  8 0.43
S-wave upstroke, ms 39  7 38  8 0.59
S-wave upstroke >55 ms 1 (2) 0 (0) 1.00
T-wave inversions 3 (5) 2 (13) 0.27
Values are n (%) or mean  SD. p by independent Student t test or chi-square test.
RBBB ¼ right bundle branch block; other abbreviations as in Table 2.
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6arrhythmic events increased signiﬁcantly when
adding the 2 early echocardiographic markers of
arrhythmic events, RV diameter and RV mechanical
dispersion, both in early ARVC (chi-square increased
from 4.7 to 10.0, p ¼ 0.05 [Figure 4A]; AIC 58 and 57,
respectively) and in the entire ARVC population (chi-
square increased from 28.1 to 48.1, p < 0.001
[Figure 4B]; AIC 155 and 139, respectively).
FEASIBILITY AND VARIABILITY ANALYSES. LV and
RV strain analyses could be performed in 89% and
82% of patients and 88% and 96% of segments could
be analyzed, respectively. Intraobserver and inter-
observer intraclass correlation for LV global longitu-
dinal strain and LV mechanical dispersion, were 0.98
(95% CI: 0.92 to 0.99) and 0.94 (95% CI: 0.77 to 0.99)
and 0.95 (95% CI: 0.81 to 0.99) and 0.91 (95% CI: 0.67
to 0.98), respectively, and for RV global longitudinal
strain and RV mechanical dispersion, values were
0.98 (95% CI: 0.92 to 0.99) and 0.83 (95% CI: 0.40 to
0.95), respectively, and 0.87 (95% CI: 0.53 to 0.97)
and 0.81 (95% CI: 0.35 to 0.95), respectively.
DISCUSSION
Risk stratiﬁcation of arrhythmias and SCD in subjects
with ARVC is difﬁcult and most challenging in theearly stages of ARVC. In this study, 21% of ARVC
subjects with early disease had experienced
arrhythmic events, underlining the importance of
identifying early markers of arrhythmias. This study
showed that both electrical parameters by signal-
averaged ECGs and parameters from echocardiogra-
phy were markers of arrhythmic events in early ARVC
disease. Of importance, the addition of a few echo-
cardiographic parameters to electrical measures
improved identiﬁcation of subjects with a history of
arrhythmic events.
RV STRUCTURAL AND FUNCTIONAL CHANGES. In
the total ARVC population, RV function was worse
and RV dimensions were larger in those with a history
of arrhythmic events, reﬂecting the well-known RV
affection in ARVC and its relation to ventricular ar-
rhythmias. Interestingly, RV diameter was a good
marker of arrhythmic events, a parameter easily ob-
tained and not included in the current TFC 2010 (5).
However, the TFC 2010 is a diagnostic score and was
not intended for identifying subjects with arrhythmic
events. Our study may imply that RV diameter
$41 mm might be associated with increased
arrhythmic risk. RVOT diameter, which is included in
the TFC 2010, was also a marker of arrhythmic events.
Interestingly, the optimal RVOT diameter to detect
patients with arrhythmic events was 34 mm and
therefore even lower than the TFC 2010 diagnostic
value (36 mm) (5).
Importantly, echocardiographic parameters were
also arrhythmic markers in early ARVC with larger RV
diameter and more pronounced RV mechanical
dispersion in subjects with a history of arrhythmic
events. These ﬁndings may indicate that dilation
without visible affection of ventricular function may
be the ﬁrst RV changes and may imply a patient’s
transition to a level of higher risk of ventricular
arrhythmia, although the retrospective study design
inhibits interpretation of cause and effect. Mechani-
cal dispersion, reﬂecting inhomogeneous contraction,
has previously been shown to be a marker of
arrhythmias in ARVC and other cardiac diseases
(7,12–15). In ARVC, structural changes, and ﬁbrosis in
particular, are likely substrates for the increased
mechanical dispersion. RV mechanical dispersion in
ARVC detects segments with subtle dyskinesia in
early disease and may reﬂect the start of ﬁbrosis and
arrhythmic risk. We have previously shown that
asymptomatic ARVC mutation-positive family mem-
bers also had more pronounced RV mechanical
dispersion than healthy controls, indicating a con-
tinuum of risk (7). The current study included a large
cohort and focused on arrhythmias in early disease
FIGURE 3 Correlation Between Filtered QRS Duration and RV Mechanical Dispersion in
Early ARVC
130
120
110
100
90
0 20 40 60
RV Mechanical Dispersion (ms)
Fi
lte
re
d 
QR
S 
(m
s)
R = 0.38
p = 0.009
y = 104 + 0.22x
Arrhythmic events No arrhythmic events
Pink dots: subjects with arrhythmic events; green dots: subjects without arrhythmic
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Figures 1 and 2.
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7and showed the additive effect of imaging to elec-
trical parameters in detecting high risk individuals.
LV STRUCTURAL AND FUNCTIONAL CHANGES. LV
affection in ARVC is now commonly recognized (16).
In the total ARVC population, parameters of LV
function and timing, including LVEF, were markers
of previous arrhythmic events. These ﬁndings sup-
port that overt ARVC disease commonly include the
left ventricle and that LV dysfunction is an important
risk factor of cardiac death (17). The relatively small
difference in LVEF between those with and without
arrhythmic events may be explained by the high
proportion of patients with early disease, with no
affection of LV parameters. Our results may indicate
that onset of LV dysfunction occurred later compared
with RV dysfunction in our population. This study
cannot answer if the relatively preserved LV function
was due to a future RV-predominant ARVC type in
our population. Future studies should investigate if
LV dysfunction precedes early RV dysfunction in
patients who develop LV-predominant ARVC disease.
However, in early ARVC, the future predominant
ventricle of disease remains unknown and both
ventricles should therefore be assessed carefully.
ELECTRICAL PARAMETERS. Pathological signal-
averaged ECGs are common in early ARVC (18).
Our study supports this ﬁnding, with one-third of pa-
tients with early ARVC showing pathological signal-
averaged ECGs. However, the value of signal-
averaged ECG in risk stratiﬁcation of arrhythmias is
less clear. Some studies have reported signal-averaged
ECG parameters to be associated with arrhythmic risk
and to relate to the extent of myocardial ﬁbrosis
(19,20). In our study, these parameters weremarkers of
arrhythmic events in early ARVC, emphasizing the
importance of this assessment in early disease. In pa-
tients with overt ARVC, signal-averaged ECGs were
clearly pathological, but were not markers of
arrhythmic events, indicating a threshold value for
arrhythmic risk. In the total ARVC population, also the
presence of T-wave inversions and epsilon waves were
markers of arrhythmic events.
EARLY ARVC ARRHYTHMIC RISK ASSESSMENT.
Current risk stratiﬁcation of SCD and hence ICD in-
dications are based on the presence of previous syn-
cope, VT or aborted cardiac arrest, and RV/LV
dysfunction, proband status, accumulated athletic
activity, and a deﬁnite ARVC diagnosis by TFC 2010
(6,21–24). However, these markers are most useful in
overt ARVC. We suggest including both electrical and
echocardiographic parameters to assess arrhythmic
risk in early ARVC. The addition of RV diameter and
RV mechanical dispersion improved the ability toidentify patients with arrhythmic events compared
with the electrical changes given by the TFC 2010
alone (Figure 4), both in early ARVC and in the total
ARVC population. Interestingly, mechanical disper-
sion was related to electrical parameters, indicating
that pronounced mechanical dispersion may reﬂect
early electromechanical interactions important for
arrhythmogenicity.
In a recent paper, time from onset of QRS to start of
regional shortening in the sub-tricuspid area was a
marker of ventricular arrhythmias in asymptomatic
ARVC mutation carriers (25), emphasizing the role of
echocardiography in risk stratiﬁcation. Alterations in
s0 have also been described in ARVC, including early
ARVC (26,27).
In our population, only 1 subject with early ARVC
had an S-wave upstroke >55 ms, which has previously
been described as a common and early ﬁnding in
ARVC (9,25) and a predictor of arrhythmic events (25).
FIGURE 4 Chi-Square Statistics for Models to Identify Subjects With Arrhythmic Events in Early ARVC (n ¼ 73) and the Total ARVC
Population (n ¼ 162)
p = 0.05 p < 0.001
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Electrical abnormalities were deﬁned according to the Task Force Criteria revised in 2010 as epsilon waves in V1 to V3, pathological signal-
averaged ECG, and T-wave inversions in V1-V2 or beyond. RV diameter and RV mechanical dispersion were included as continuous variables.
Chi-Square statistics were used a measure of the ability to detect arrhythmic events and showed that the model for identifying subjects with
arrhythmic events was improved both in early ARVC (A) (chi-Square increased from 4.7 to 10.0; p ¼ 0.05) and in the total ARVC population (B)
(chi-Square increased from 28.1 to 48.1; p < 0.001) when adding measurements of RV diameter and RV mechanical dispersion to the presence
of electrical abnormalities alone. RVMD ¼ right ventricular mechanical dispersion; other abbreviations as in Figures 1 and 2.
Leren et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . - , N O . - , 2 0 1 6
Identiﬁcation of Arrhythmic Events in Early ARVC - 2 0 1 6 :- –-
8This discrepancy may be explained by the different
deﬁnitions of S-wave upstroke (9,25).
CLINICAL IMPLICATIONS. ARVC mutation-positive
family members with no apparent or only early dis-
ease constitute a substantial proportion of current
ARVC populations seen in cardiomyopathy clinics.
Risk stratiﬁcation of SCD in these individuals has not
been sufﬁciently addressed and they are currently
followed every 1 to 2 years from age 15 with Holter
monitoring, signal-averaged ECG, and echocardiog-
raphy (28). The retrospective nature of arrhythmic
events in relation to the echocardiography did not
allow for causal interpretation, but there seemed to
be an association between arrhythmias and echocar-
diographic alterations. We suggest that in subjects
with pathological signal-averaged ECG, the presence
of RV diameter $40 mm and mechanical
dispersion $37 ms might incline the clinician to more
frequent arrhythmia monitoring to detect episodes of
arrhythmias and support the evaluation of ICD
implantation.
STUDY LIMITATIONS. This study was cross-sectional
in design with the inherent limitations. The limited
number of patients with early ARVC makes the model
for identifying subjects with arrhythmic events
vulnerable to overﬁtting. Our analyses may be
confounded by inclusion of mutation-positive family
members whowill remain ARVC nonpenetrant. Future
and larger studies should prospectively follow subjects
with early ARVC disease to conﬁrm our results.All echocardiographic analyses were performed in a
blinded fashion; however, the presence of an ICD lead
might have demasked arrhythmic status in a few cases.
Cardiac magnetic resonance imaging scans were
lacking in 32% of early ARVC subjects, hence the TFC
2010 score may have been underestimated in a few
subjects.
CONCLUSIONS
Subjects with ARVC and arrhythmic events had
increased RV diameters and decreased RV and LV
function by echocardiography. In patients with early
ARVC disease, electrical parameters from signal-
averaged ECGs and the 2 RV echocardiographic pa-
rameters RV diameter and RV mechanical dispersion,
were markers of arrhythmic events. The addition of
early structural changes increased the ability to
detect subjects with arrhythmic events compared
with electrical parameters alone. We suggest
including measurements of RV diameter and RV
mechanical dispersion when evaluating arrhythmic
risk in subjects with ARVC.
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PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: ARVC is
characterized by structural and functional changes. Elec-
trical changes are shown to occur prior to structural
changes included in the 2010 TFC. However, this study
showed that 2 novel RV parameters by echocardiography,
RV mechanical dispersion and RV diameter, were also
markers of arrhythmic events in early ARVC. These mea-
sures, not included in the 2010 TFC, may be important for
risk stratiﬁcation of arrhythmias in early disease.
TRANSLATIONAL OUTLOOK: Risk stratiﬁcation of
ventricular arrhythmias in ARVC is challenging, particu-
larly in early disease. Genetic family screening has
resulted in a substantial proportion of mutation-positive
family members in ARVC clinics with no apparent or early
ARVC disease in whom risk stratiﬁcation for ventricular
arrhythmias is not fully addressed. In this study, we
showed that including novel RV measures by echocardi-
ography was superior to electrical parameters alone in
identifying subjects with a history of arrhythmic events,
both in the total ARVC population and in patients with
early ARVC disease. This might imply that in asymptom-
atic mutation-positive family members with pathological
signal-averaged ECGs, the ﬁndings of RV diameter $40
mm and mechanical dispersion $37 ms should lead the
clinician to more frequent arrhythmia monitoring to
detect episodes of ventricular arrhythmias.
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